NO166529C - Analogifremgangsmaate for fremstilling av terapeutisk aktive 2,5-pyrolidindion derivater. - Google Patents

Analogifremgangsmaate for fremstilling av terapeutisk aktive 2,5-pyrolidindion derivater.

Info

Publication number
NO166529C
NO166529C NO853069A NO853069A NO166529C NO 166529 C NO166529 C NO 166529C NO 853069 A NO853069 A NO 853069A NO 853069 A NO853069 A NO 853069A NO 166529 C NO166529 C NO 166529C
Authority
NO
Norway
Prior art keywords
pyrolide
indion
derivatives
preparation
therapeutically active
Prior art date
Application number
NO853069A
Other languages
English (en)
Other versions
NO853069L (no
NO166529B (no
Inventor
Bipinchandra Nanubhai Desai
Robert John Chorvat
Original Assignee
Corporate Patent Department G
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Corporate Patent Department G filed Critical Corporate Patent Department G
Publication of NO853069L publication Critical patent/NO853069L/no
Publication of NO166529B publication Critical patent/NO166529B/no
Publication of NO166529C publication Critical patent/NO166529C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/36Oxygen or sulfur atoms
    • C07D207/402,5-Pyrrolidine-diones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/10Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms
    • C07D211/14Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/14Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D295/145Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Materials For Photolithography (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Lubricants (AREA)
  • Treatment Of Water By Ion Exchange (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Suspension Of Electric Lines Or Cables (AREA)
  • Professional, Industrial, Or Sporting Protective Garments (AREA)
NO853069A 1984-08-03 1985-08-02 Analogifremgangsmaate for fremstilling av terapeutisk aktive 2,5-pyrolidindion derivater. NO166529C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/637,633 US4554353A (en) 1984-08-03 1984-08-03 2,5-Pyrrolidinedione derivatives useful as antiarrhythmic agents

Publications (3)

Publication Number Publication Date
NO853069L NO853069L (no) 1986-02-04
NO166529B NO166529B (no) 1991-04-29
NO166529C true NO166529C (no) 1991-08-07

Family

ID=24556766

Family Applications (1)

Application Number Title Priority Date Filing Date
NO853069A NO166529C (no) 1984-08-03 1985-08-02 Analogifremgangsmaate for fremstilling av terapeutisk aktive 2,5-pyrolidindion derivater.

Country Status (18)

Country Link
US (1) US4554353A (no)
EP (1) EP0170281B1 (no)
JP (1) JPS6143164A (no)
AT (1) ATE53575T1 (no)
AU (1) AU581914B2 (no)
CA (1) CA1270833C (no)
DE (1) DE3578172D1 (no)
DK (1) DK163661C (no)
ES (1) ES8703421A1 (no)
FI (1) FI80876C (no)
GR (1) GR851890B (no)
IE (1) IE60110B1 (no)
IL (1) IL75985A (no)
NO (1) NO166529C (no)
NZ (1) NZ212955A (no)
PH (1) PH20948A (no)
PT (1) PT80905B (no)
ZA (1) ZA855860B (no)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USD973876S1 (en) * 2020-03-18 2022-12-27 Stephen A. Young Blood sampling device

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2666060A (en) * 1951-09-11 1954-01-12 Ciba Pharm Prod Inc 1, 3-bisaminoalkyl-3-phenyl-2, 5-dioxopyrrolidines
CH306904A (de) * 1951-09-11 1955-04-30 Ciba Geigy Verfahren zur Herstellung eines neuen Dioxopyrrolidins.
FR1079802A (fr) * 1952-02-26 1954-12-02 Parke Davis & Co Fabrication de dérivés de la succinimide

Also Published As

Publication number Publication date
EP0170281B1 (en) 1990-06-13
CA1270833A (en) 1990-06-26
EP0170281A2 (en) 1986-02-05
CA1270833C (en) 1990-06-26
ES545870A0 (es) 1987-02-16
FI852990A0 (fi) 1985-08-02
DK163661B (da) 1992-03-23
FI852990L (fi) 1986-02-04
IL75985A (en) 1988-07-31
AU581914B2 (en) 1989-03-09
NZ212955A (en) 1988-03-30
DK353785D0 (da) 1985-08-02
ZA855860B (en) 1986-10-29
DE3578172D1 (de) 1990-07-19
FI80876B (fi) 1990-04-30
ATE53575T1 (de) 1990-06-15
NO853069L (no) 1986-02-04
JPS6143164A (ja) 1986-03-01
AU4569385A (en) 1986-02-06
IE60110B1 (en) 1994-06-01
NO166529B (no) 1991-04-29
IL75985A0 (en) 1985-12-31
PT80905A (en) 1985-09-01
DK163661C (da) 1992-08-24
JPH0566942B2 (no) 1993-09-22
IE851932L (en) 1986-02-03
PH20948A (en) 1987-06-10
PT80905B (pt) 1987-09-30
EP0170281A3 (en) 1986-06-25
FI80876C (fi) 1990-08-10
US4554353A (en) 1985-11-19
GR851890B (no) 1985-12-09
ES8703421A1 (es) 1987-02-16
DK353785A (da) 1986-02-04

Similar Documents

Publication Publication Date Title
NO163857C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tiazolidindionforbindelser.
HK129093A (en) N-tert-butyl-decahydro-2(3-amino-2-hydroxy-4-phenyl-butyl)isoquinoline-3-carboxamide & asparaginyl derivatives thereof
NO163568C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive kinolonkarboksylsyrederivater.
NO166281C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,1-disubstituerte cyklopropanderivater.
NO163331C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive 6,7-disubstituerte 1-cyklopropyl-1,4-dihydro-4-okso-1,8-naftyridin-3-karboksylsyrer.
DE3584608D1 (de) Amidabkoemmlinge.
AU581855B2 (en) 1-(4'-alkylsulphonylphenyl)-2-amino-1, 3-propanediol n-substituted derivatives
NO167286C (no) Fremgangsmaate for fremstilling av terapeutisk aktive benzotiazepin-derivater.
NO169442C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive prolinderivater og lignende forbindelser
NO166529C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 2,5-pyrolidindion derivater.
AU581856B2 (en) 1-(4'-alkylthiophenyl)-2-amino-1, 3-propanediol N-substituted derivatives
NO162468C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 12-amino-pyridazino (4[,5[;3,4)-pyrrolo-( 2,1-a)-isokinolinderivater.
NO167801C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 2,2'-bi-1h-imidazolderivater.
NO171499C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 5,6-dihydro-4h-cyklo-penta(b)tiofen-6-karboksylsyre-derivater
FI894813A0 (fi) Menetelmä terapeuttisesti aktiivisten 2-metoksikarbonyylisubstituoitujen N,N'-di(trimetoksibentsoyyli)piperatsiinijohdannaisten valmistamiseksi
NO863005D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive 1,4,5,6,7,8-heksahydro-2-alkyl-4-aryl-5-okso-1,7-naftyridin-3-karboksylsyreesterderivater.
AU2013888A (en) Uricosuric composition
AU7748487A (en) 2-amino-3-aroyl-omega-oxobenzenebutanoic acids and esters
NO164657C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,8-nafthyridinoner.
NO165798C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,3-disubstituerte 2-oksindol-derivater.
YU47871B (sh) Derivati aminokiselina